Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 35, Issue 6, 2016, Pages 731-742

  Chiu, Peter ^a   Schaffer, Justin M ^a   Oyer, Philip E ^a   Pham, Michael ^b   Banerjee, Dipanjan ^b   Joseph Woo, Y ^a   Ha, Richard ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

heart transplantation; mechanical circulatory support; panel reactive antibody; survival; ventricular assist devices

Indexed keywords

PANEL REACTIVE ANTIBODY;

ADULT; ALLOIMMUNITY; ALLOSENSITIZATION; ARTICLE; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; COHORT ANALYSIS; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INTRAAORTIC BALLOON PUMP; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MECHANICAL CIRCULATORY SUPPORT; MIDDLE AGED; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; RIGHT VENTRICULAR ASSIST DEVICE; SURGICAL MORTALITY; SURVIVAL; TOTAL ARTIFICIAL HEART; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EXTRACORPOREAL MEMBRANE OXYGENATION; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84975126889     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.12.023     Document Type: Article

References (35)

1. L.U. Nwakanma, J.A. Williams, E.S. Weiss, S.D. Russell, W.A. Baumgartner, and J.V. Conte Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era Ann Thorac Surg 84 2007 1556 1562 discussion 1562-3
2. J.M. Schaffer, S.K. Singh, B.A. Reitz, P.E. Oyer, R.C. Robbins, and H.R. Mallidi Heart transplant graft survival is improved after a reduction in panel reactive antibody activity J Thorac Cardiovasc Surg 145 2013 555 564 discussion 564-5
3. L.H. Lund, L.B. Edwards, A.Y. Kucheryavaya, and et al. International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report - 2013; focus theme: age J Heart Lung Transplant 32 2013 951 964
4. K.D. Aaronson, M.J. Eppinger, D.B. Dyke, S. Wright, and F.D. Pagani Left ventricular assist device therapy improves utilization of donor hearts J Am Coll Cardiol 39 2002 1247 1254
5. T. Dardas, N.A. Mokadam, F. Pagani, K. Aaronson, and W.C. Levy Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1a time J Am Coll Cardiol 60 2012 36 43
6. C.J. Wozniak, J. Stehlik, B.C. Baird, and et al. Ventricular assist devices or inotropic agents in status 1a patients? Survival analysis of the united network of organ sharing database Ann Thorac Surg 97 2014 1364 1371 discussion 1371-2
7. I. George, P. Colley, M.J. Russo, and et al. Association of device surface and biomaterials with immunologic sensitization after mechanical support J Thorac Cardiovasc Surg 135 2008 1372 1379
8. D.A. Bull, B.B. Reid, C.H. Selzman, and et al. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation J Thorac Cardiovasc Surg 140 2010 169 173
9. S.G. Drakos, A.G. Kfoury, J.R. Kotter, and et al. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization J Heart Lung Transplant 28 2009 838 842
10. P.C. Austin Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples Stat Med 28 2009 3083 3107
11. K.J. Rothman No adjustments are needed for multiple comparisons Epidemiology 1 1990 43 46
12. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
13. J.M. Bland, and D.G. Altman The logrank test BMJ 328 2004 1073
14. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
15. P.C. Austin The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments Stat Med 33 2014 1242 1258
16. I.R. White, P. Royston, and A.M. Wood Multiple imputation using chained equations: issues and guidance for practice Stat Med 30 2011 377 399
17. A. Marshall, D.G. Altman, P. Royston, and R.L. Holder Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study BMC Med Res Methodol 10 2010 7
18. I.R. White, and P. Royston Imputing missing covariate values for the cox model Stat Med 28 2009 1982 1998
19. J.W. Graham, A.E. Olchowski, and T.D. Gilreath How many imputations are really needed? Some practical clarifications of multiple imputation theory Prev Sci 8 2007 206 213
20. E.A. Stuart Matching methods for causal inference: a review and a look forward Stat Sci 25 2010 1 21
21. R. Mitra, and J.P. Reiter A comparison of two methods of estimating propensity scores after multiple imputation Stat Methods Med Res 2012 http://www.ncbi.nlm.nih.gov/pubmed/22687877. Accessed April 17, 2015
22. D. Rubin Multiple imputation for nonresponse in surveys 1987 Wiley New York, NY
23. D.R. Cox Regression models and life-tables J R Stat Soc Series B Stat Methodol 34 1972 187 220
24. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
25. D.W. Hosmer, S. Lemeshow, and S. May Applied survival analysis: regression modeling of time-to-event data 2008 Wiley-Interscience Hoboken, NJ
26. H. Akaike A new look at the statistical model identification IEEE Trans Automat Contr 19 1974 716 723
27. M.R. Costanzo, A. Dipchand, R. Starling, and et al. International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients J Heart Lung Transplant 29 2010 914 956
28. F.D. Pagani, D.B. Dyke, S. Wright, R. Cody, and K.D. Aaronson Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival J Heart Lung Transplant 20 2001 646 653
29. N. Moazami, S. Itescu, M.R. Williams, M. Argenziano, A. Weinberg, and M.C. Oz Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support J Heart Lung Transplant 17 1998 876 880
30. M.S. Leffell, D. Kim, R.M. Vega, and et al. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation Transplantation 97 2014 525 533
31. S.G. Drakos, J.C. Stringham, J.W. Long, and et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions J Thorac Cardiovasc Surg 133 2007 1612 1619
32. G.J. Arnaoutakis, T.J. George, A. Kilic, and et al. Effect of sensitization in us heart transplant recipients bridged with a ventricular assist device: update in a modern cohort J Thorac Cardiovasc Surg 142 2011 1236 1245 1245 e1231
33. G.S. Kumpati, D.J. Cook, E.H. Blackstone, and et al. HLA sensitization in ventricular assist device recipients: does type of device make a difference? J Thorac Cardiovasc Surg 127 2004 1800 1807
34. J.N. Nativi, S.G. Drakos, A.Y. Kucheryavaya, and et al. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 30 2011 854 861
35. N. Shankar, R. Daly, J. Geske, and et al. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay Transplantation 96 2013 324 330